Share

Evaluation in humans of ELF-EMF exposure on chromogranin A, a marker of neuroendocrine tumors and stress

PAPERmanual2019cohortEffect: mixedEvidence: Low

Abstract

Evaluation in humans of ELF-EMF exposure on chromogranin A, a marker of neuroendocrine tumors and stress Touitou Y, Lambrozo J, Mauvieux B, Riedel M. Evaluation in humans of ELF-EMF exposure on chromogranin A, a marker of neuroendocrine tumors and stress. Chronobiol Int. 2019 Nov 4:1-8. doi: 10.1080/07420528.2019.1683857. Abstract Chromogranin A (CgA), which is a major protein in adrenal chromaffin cells and adrenergic neurons, is a clinically relevant endocrine and neuroendocrine tumor marker including pheochromocytomas, neuroblastomas, and related neurogenic tumors. In this study, we looked at the effect in humans of chronic daily exposure to a 50-Hz magnetic field. We examined in 15 men (38.0 ± 0.9 years) the effects of chronic daily exposure to a 50-Hz magnetic field for 1-20 yrs both at home and at work. EMDEX II dosimeters were used to record magnetic field all day long every 30 s. for 1 week. The weekly geometric mean of the individual exposures ranged from 0.1 to 2.6 μT. Blood samples were taken hourly between 20:00 h and 08:00 h. CgA patterns of exposed subjects were compared to age-matched controls. The results of exposed subjects were compared with those for 15 unexposed men who served as controls and whose individual exposure was ten times lower ranging from 0.004 to 0.092 μT. This work shows that in the control group the serum CgA levels exhibited a nighttime peak with a progressive decline of the serum concentrations and a nadir in the morning. Both the profile and the serum concentrations of CgA, a marker of neuroendocrine tumors and stress, did not appear to be impaired in the subjects chronically exposed over a long period (up to 20 yrs) to magnetic fields though a trend toward lower levels were found at the highest exposure (>0.3 μT). This does not rule out, however, that the potential deleterious risk of ELF-EMF on frail populations such as children and the elderly may be greater at low exposure and should hence be documented, at least for their residential exposure. ncbi.nlm.nih.gov

AI evidence extraction

At a glance
Study type
cohort
Effect direction
mixed
Population
Men (mean age 38.0 ± 0.9 years); exposed group compared with age-matched male controls
Sample size
30
Exposure
ELF residential and occupational · chronic daily exposure for 1–20 years; personal dosimetry for 1 week
Evidence strength
Low
Confidence: 74% · Peer-reviewed: yes

Main findings

In controls, serum CgA showed a nighttime peak with progressive decline to a morning nadir. In chronically exposed men (50-Hz magnetic field), CgA profile and concentrations did not appear impaired versus controls, though a trend toward lower levels was noted at the highest exposure (>0.3 µT).

Outcomes measured

  • Serum chromogranin A (CgA) levels
  • Nighttime profile/circadian pattern of CgA

Limitations

  • Small sample size (15 exposed
  • 15 controls)
  • Exposure measurement reported for 1 week despite long-term exposure history (1–20 years)
  • Only adult men studied
  • results may not generalize to other groups
  • Trend at highest exposure reported without clear statistical detail in abstract

Suggested hubs

  • occupational-exposure (0.7)
    Exposure assessed at work and at home over years; personal dosimetry used.
View raw extracted JSON
{
  "study_type": "cohort",
  "exposure": {
    "band": "ELF",
    "source": "residential and occupational",
    "frequency_mhz": null,
    "sar_wkg": null,
    "duration": "chronic daily exposure for 1–20 years; personal dosimetry for 1 week"
  },
  "population": "Men (mean age 38.0 ± 0.9 years); exposed group compared with age-matched male controls",
  "sample_size": 30,
  "outcomes": [
    "Serum chromogranin A (CgA) levels",
    "Nighttime profile/circadian pattern of CgA"
  ],
  "main_findings": "In controls, serum CgA showed a nighttime peak with progressive decline to a morning nadir. In chronically exposed men (50-Hz magnetic field), CgA profile and concentrations did not appear impaired versus controls, though a trend toward lower levels was noted at the highest exposure (>0.3 µT).",
  "effect_direction": "mixed",
  "limitations": [
    "Small sample size (15 exposed, 15 controls)",
    "Exposure measurement reported for 1 week despite long-term exposure history (1–20 years)",
    "Only adult men studied; results may not generalize to other groups",
    "Trend at highest exposure reported without clear statistical detail in abstract"
  ],
  "evidence_strength": "low",
  "confidence": 0.74,
  "peer_reviewed_likely": "yes",
  "keywords": [
    "ELF-EMF",
    "50-Hz magnetic field",
    "chromogranin A",
    "CgA",
    "neuroendocrine tumor marker",
    "stress marker",
    "personal dosimetry",
    "EMDEX II",
    "circadian profile",
    "occupational exposure",
    "residential exposure"
  ],
  "suggested_hubs": [
    {
      "slug": "occupational-exposure",
      "weight": 0.78,
      "reason": "Exposure assessed at work and at home over years; personal dosimetry used."
    }
  ]
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.

NNEMF synthesis

Synthesis pending.

Original record: rfsafe.org paper 1650

Evaluation in humans of ELF-EMF exposure on chromogranin A, a marker of neuroendocrine tumors and stress · Non-native EMF